Tamoxifen inhibition of protein kinase C
โ Scribed by Horgan, K.; Cooke, Eryl; Hallett, M.B.; Mansel, R.E.
- Book ID
- 122339880
- Publisher
- Elsevier Science
- Year
- 1986
- Weight
- 178 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## SYNOPSIS The triphenylethylene antiestrogen trans-tamoxifen is an effective antitumor agent used in the treatment of human breast cancer. While the antiestrogenic activity of trans- tamoxifen clearly plays an important role in its tumoricidal action, some of the biological effects of trans-tamo
BACKGROUND. Inhibition of protein kinase C (PKC) and modulation of transforming growth factor-โค (TGF-โค) are both associated with tamoxifen treatment, and both appear to be important in the regulation of prostate cancer cell growth. Investigations were performed which sought to measure the efficacy,